Skip to main content
. 2021 Sep 9;7:116. doi: 10.1038/s41523-021-00318-5

Table 1.

Diagnostic characteristics from the initial 21 surgical cases with intraoperative MS analysis.

Invasive carcinoma type Tumor size (cm) Overall histological grade DCIS/LCIS present? AJCC stage ER PR Her-2
1 Mixed 1.6 Poor DCIS T1c N0 (sn) + +
2 Mixed 1.5 Moderate LCIS pT1c N0 (sn) + +
3 Mixed 1.1 0.25 Moderate LCIS pT1c N0 (sn) + +
4 Ductal 1.4 Well Mixed T1c N1a + + +/−
5 Ductal 1 Moderate pT1b N0 (sn) + +
6 Ductal 1.6 Well DCIS T1c N0 (sn) + +
7 Ductal 1.7 Poor DCIS pT1c N0 (sn)
8 Ductal 2.1 Poor pT2 N0(sn)
9 Ductal

0.8

0.5

Well DCIS pm T1b N0 (sn) + +
10 Ductal 0.9 Well DCIS T1b N0(sn) + +
11 Ductal 0.6 Moderate DCIS pT1b Nx + +
12 Ductal with spindle features 0.6 Moderate DCIS pT1b N1a (sn)
13 Ductal 1.9 Poor DCIS pT1c N0 (sn) + +
14 Ductal 1.9 Moderate pT1c N0 (sn) + +
15 Mixed 0.7 Well pT1b N0 + +
16 Lobular 0.4; <0.1 Moderate LCIS pT1b N0 (sn) + +
17 Tubular 0.8 Well pT1bN0 + +
18 Lobular 0.9 Well pT1b N0(sn) + +
19 Ductal; Mixed 1.3; 0.9 Moderate; Well DCIS pT1c N1mi (two loci) + +
20 Micropapillary mucinous 2.4 Moderate DCIS pT2 N0 (sn) + +
21 Mixed 1.5 Moderate DCIS pT1c N0 + +

DCIS ductal carcinoma in situ, LCIS lobular carcinoma in situ, LVI lymphovascular invasion, ER estrogen receptor, PR progesterone receptor, Nx No lymph nodes available for evaluation.

*SRS analyzed.